Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years
Ontology highlight
ABSTRACT: Serum pepsinogen (PG) levels are considered reliable markers for progression of atrophic gastritis with a stepwise reduction in the serum PG I level or PG I/II ratio. A combination of serum PG levels and Helicobacter pylori serology are used as a biomarker strategy for detection of individuals at increased risk of gastric neoplasm based on Correa’s hypothesis. The investigators aimed to uncover whether this combination method could predict the risk of gastric neoplasms and the progression of chronic atrophic gastritis after 3 years. All the participants will be followed for an expected average of 3 years.
DISEASE(S): Atrophy,Intestinal Metaplasia,Metaplasia,Gastric Adenoma,Gastric Atrophy,Gastric Cancer,Gastritis, Atrophic,Gastric Neoplasm,Adenoma,Stomach Neoplasms,Gastritis
PROVIDER: 2142623 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA